You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 148 No. 9, September 1994 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Articles
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Acrodermatitis Enteropathica, Zinc Metabolism, Copper Status, and Immune Function

Brittmarie Sandström, PhD; Åke Cederblad, MSc; Bo S. Lindblad, MD; Bo Lönnerdal, PhD

Arch Pediatr Adolesc Med. 1994;148(9):980-985.


Abstract



Objective
To study zinc metabolism, copper status, and immune function in a patient with acrodermatitis enteropathica.

Research Design
Case report.

Patient
A 16-year-old boy with acrodermatitis enteropathica.

Intervention
Change of zinc supplementation dosage from 1000 to 525 µmol/d.

Measurements and Results
Zinc metabolism was studied with an oral dose of zinc chloride Zn 65 and whole-body counting at both zinc dosages. Zinc, copper status, and immune indexes were also measured at both dosages. The higher dosage of zinc supplementation was found to induce a state of low copper status and immune dysfunction. Lowering the dosage normalized these indexes. Zinc absorption in this patient was found to be within the reference range for healthy subjects. At the lower dosage, zinc retention and the rate of whole-body turnover also normalized. These results suggest that the primary lesion in acrodermatitis enteropathica is a cellular defect in zinc metabolism rather than an impairment of zinc absorption.

Conclusion
Zinc and copper status and immune function should be monitored regularly in patients with acrodermatitis enteropathica to provide a proper dosage of zinc during different physiologic stages.

(Arch Pediatr Adolesc Med. 1994;148:980-985)



Author Affiliations



From the Research Department of Human Nutrition, Royal Veterinary and Agricultural University, Frederiksberg, Denmark (Dr Sandström); the Department of Radiation Physics, University of Gothenburg (Sweden) (Mr Cederblad); the Department of Pediatrics, St Görans Hospital, Stockholm, Sweden (Dr Lindblad); and the Department of Nutrition, University of California, Davis (Dr Lönnerdal). Dr Lindblad is now with The Aga Khan University, Karachi, Pakistan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The mouse acrodermatitis enteropathica gene Slc39a4 (Zip4) is essential for early development and heterozygosity causes hypersensitivity to zinc deficiency
Dufner-Beattie et al.
Hum Mol Genet 2007;16:1391-1399.
ABSTRACT | FULL TEXT  

Identification of a Mutation in SLC30A2 (ZnT-2) in Women with Low Milk Zinc Concentration That Results in Transient Neonatal Zinc Deficiency
Chowanadisai et al.
J. Biol. Chem. 2006;281:39699-39707.
ABSTRACT | FULL TEXT  

Picture of the Month
Ghali et al.
Arch Pediatr Adolesc Med 1996;150:99-100.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.